Minireviews
Copyright ©The Author(s) 2022.
World J Gastroenterol. Aug 7, 2022; 28(29): 3803-3813
Published online Aug 7, 2022. doi: 10.3748/wjg.v28.i29.3803
Table 3 Summary of studies on reporting endoscopic ultrasound-guided rendezvous procedures
Ref.
Study design (patient number)
Malignant biliary obstruction
Success rate via EHBD
Success rate via IHBD
Overall technical success rate
Overall complication rate
Iwashita et al[10] (2016)Prospective (n = 20)60% (12/20)86.7% (13/15)75% (3/4)80% (16/20)15% (3/20); Hematoma (5%); Pancreatitis (10%)
Tang et al[40] (2016)Retrospective (n = 25)52% (13/25)83.3% (20/24)0 (0/1)80% (20/25)16% (4/25); Pancreatitis (12%); Cholangitis (4%)
Okuno et al[32] (2017)Retrospective (n = 39)62.5% (24/39)84.6% (22/26)68.8% (11/16)78.6% (33/42)16.7% (7/42); Pneumomediastinum (4.8%); Retroperitoneal perforation (2.4%); Cholangitis (2.4%); Peritonitis (4.8%); Pancreatitis (2.4%)
Nakai et al[41] (2017)Retrospective (n = 30)30% (9/30)NANA93.3% (28/30)23.3% (7/30); Pancreatitis (10.0 %); Bile peritonitis (3.3 %); Cholangitis (3.3 %); Aspiration pneumonia (3.3 %); Gastric mucosa laceration (3.3 %)
Shiomi et al[42] (2018) Prospective (n = 20)40% (8/20)83.3% (10/12)87.5% (7/8)85% (17/20)15% (3/20); Biliary peritonitis (10%); Pancreatitis (5%)
Martínez et al[43] (2019)Retrospective (n = 27)081.5 % (22/27)-81.5 % (22/27)11.1% (3/27); Pneumomediastinum (3.7%); Bile leak (3.7%); Pancreatitis (3.7%)
Matsubara et al[31] (2020)Retrospective (n = 16)68.8% (11/16)93.3% (14/15)100% (2/21)100% (16/16)6.3% (1/16); Pancreatitis (6.3%)
Overalln = 17743.5% (77/177)84.9% (101/119)74.2% (23/31)84.4% (152/180)15.6% (28/180); Pancreatitis (6.7%); Bile leak/peritonitis (3.3%); Cholangitis (1.7%); Pneumomediastinum (1.7%); Retroperitoneal perforation (0.6%); Hematoma (0.6%); Aspiration pneumonia (0.6%); Gastric mucosa laceration (0.6%)